Document Detail


Determinants of success in national programs to eliminate lymphatic filariasis: a perspective identifying essential elements and research needs.
MedLine Citation:
PMID:  18840733     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The Global Programme to Eliminate Lymphatic Filariasis (GPELF) was launched in 2000. To understand why some national programs have been more successful than others, a panel of individuals with expertise in LF elimination efforts met to assess available data from programs in 8 countries. The goal was to identify: 1) the factors determining success for national LF elimination programs (defined as the rapid, sustained reduction in microfilaremia/antigenemia after repeated mass drug administration [MDA]); 2) the priorities for operational research to enhance LF elimination efforts. Of more than 40 factors identified, the most prominent were 1) initial level of LF endemicity; 2) effectiveness of vector mosquitoes; 3) MDA drug regimen; 4) population compliance. Research important for facilitating program success was identified as either biologic (i.e., [1] quantifying differences in vectorial capacity; [2] identifying seasonal variations affecting LF transmission) or programmatic (i.e., [1] identifying quantitative thresholds, especially the population compliance levels necessary for success, and the antigenemia or microfilaremia prevalence at which MDA programs can stop with minimal risk of resumption of transmission; [2] defining optimal drug distribution strategies and timing; [3] identifying those individuals who are "persistently non-compliant" during MDAs, the reasons for this non-compliance and approaches to overcoming it). While addressing these challenges is important, many key determinants of program success are already clearly understood; operationalizing these as soon as possible will greatly increase the potential for national program success.
Authors:
Dominique Kyelem; Gautam Biswas; Moses J Bockarie; Mark H Bradley; Maged El-Setouhy; Peter U Fischer; Ralph H Henderson; James W Kazura; Patrick J Lammie; Sammy M Njenga; Eric A Ottesen; Kapa D Ramaiah; Frank O Richards; Gary J Weil; Steven A Williams
Related Documents :
6925093 - Teen advocate program.
16687703 - Hivcorps: using volunteers to rapidly expand hiv health services across zambia.
15271043 - Evaluating the impact of moving from discipline-based to integrated assessment.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The American journal of tropical medicine and hygiene     Volume:  79     ISSN:  1476-1645     ISO Abbreviation:  Am. J. Trop. Med. Hyg.     Publication Date:  2008 Oct 
Date Detail:
Created Date:  2008-10-08     Completed Date:  2008-10-21     Revised Date:  2011-11-08    
Medline Journal Info:
Nlm Unique ID:  0370507     Medline TA:  Am J Trop Med Hyg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  480-4     Citation Subset:  AIM; IM    
Affiliation:
Lymphatic Filariasis Support Center, Task Force for Child Survival and Development, Decatur, Georgia 30030, USA. dkyelem@taskforce.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Elephantiasis, Filarial / drug therapy,  epidemiology,  prevention & control*
Humans
Program Evaluation
Research
Grant Support
ID/Acronym/Agency:
U19 AI065717-04/AI/NIAID NIH HHS
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Dracunculiasis eradication: neglected no longer.
Next Document:  Risk factors for dengue virus infection in rural Amazonia: population-based cross-sectional surveys.